Syros(SYRS) - 2022 Q2 - Earnings Call Transcript

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Courtney Solberg - Manager of Corporate Communications & Investor Relations Nancy Simonian - Chief Executive Officer David Roth - Chief Medical Officer Jason Haas - Chief Financial Officer Conference Call Participants Phil Nadeau - Cowen & Company Jason Butler - JMP Securities Mark Breidenbach - Oppenheimer Operator Good morning, and welcome to Syros Pharmaceuticals Second Quarter 2022 F ...